Immunology, lymphatics and cancer therapy
Our research has overlapping interests in the biology of the immune system, lymphatics and cancer with a focus on developing novel therapeutics.
We have a strong interest in generating chemical and biological therapeutics for the treatment of medical conditions that alter the immune and lymphatic systems and a range of different cancers. Our researchers have expertise in cell sorting, bioinformatics, molecular biology, chemistry, physiology and imaging.
A particular focus for the immune researchers is the cellular response to cancer and viral infections. Our lymphatic researchers are developing an understanding of lymph node architecture and the role of lymph mediated multi-organ failure during critical illness. The cancer interest group has major themes in melanoma and immune-cell based therapeutics. The medicinal chemistry groups in this cluster have a strong reputation for drug design across a range of cancer targets.